About
Board
News
Sign Up
Contact
Visit
Home
(current)
Diseases
Genitourinary
Lung
Head and Neck
Breast
Gynecological
Skin
View all Diseases
Topics
Treatment
Early Diagnosis
Nursing
Pharmacy
Supportive Care
Policy
View all Topics
Conferences
GU Cancers
2019
BTOG
2019
UKONS
2018
NCRI
2018
ESMO
2018
EONS
2018
View all Conferences
Features
Podcasts
About
Board
News
Sign Up
Contact
Head and Neck Cancer
3:01
Is mobile symptom monitoring the way forward for patients receiving radiotherapy?
Susan Peterson
2:24
CYCORE: vital monitoring during radiotherapy for head and neck cancer reduces symptom burden
Susan Peterson
3:09
M7824: a promising novel antibody for HPV-associated cancers
James Gulley
3:04
A breakthrough for oral mucositis management with avisopasem manganese
Ezra Cohen
2:28
Palbociclib for platinum-resistant metastatic head and neck cancer
Douglas Adkins
2:53
Positive results for palbociclib/cetuximab therapy in head and neck cancer
Ezra Cohen
4:03
KEYNOTE-040: groundbreaking results for pembrolizumab in head and neck cancer
Ezra Cohen
3:08
Improved survival, toxicity & QoL with pembrolizumab in head and neck cancer
Kevin Harrington
2:51
MASTERKEY-232: T-VEC not the way forward in relapsed head and neck cancer
Kevin Harrington
4:04
Hyperprogressive disease in lung cancer
Benjamin Besse
3:10
The risks of radioactive iodine treatment in thyroid cancer
Remco Molenaar
1:59
Pembrolizumab in the treatment of head and neck cancer: is there more to the story?
Jean-Pascal Machiels
1:12
Immunotherapy: changing the landscape of cancer treatment
Jean-Pascal Machiels
2:14
Innovative approaches to the treatment of head and neck cancer
Jean-Pascal Machiels
3:35
Is there a use for anti-PDL-1 antibodies in recurrent head and neck cancer?
Ezra Cohen
2:38
Exciting results of the SCORES trial
Ezra Cohen
Previous
1
2
3
Next